Inhibitory Effect of KW-3635, a New Thromboxane A2-Receptor Antagonist, on Arterial Thrombosis in Guinea Pigs

The Japanese Journal of Pharmacology

Akira Karasawa¹  Katsuya Higo¹ 

[1] Department of Pharmacology, Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.

关键词: KW-3635;    Thromboxane A2-receptor antagonist;   

DOI  :  10.1254/jjp.63.521

学科分类：药理学

来源: Nihon Yakuri Gakkai Henshuubu / Japanese Pharmacological Society

【 摘 要 】

References(10)Cited-By(3)The antithrombotic effects of the thromboxane (TX) A2-receptor antagonist and aspirin were determined using a photochemically-induced arterial thrombosis model in the femoral arteries of guinea pigs. KW-3635 (sodium (E)-11-[2-(5, 6-dimethyl-1-benzimidazolyl)ethylidene]-6, 11-dihydrodibenz[b, e]-oxepine-2-carboxylate monohydrate) and BM-13505, both of which are TXA2-receptor antagonists, and aspirin inhibited the thrombus formation at the doses that inhibited the ex vivo platelet aggregation induced by sodium arachidonate (100 μM) or collagen (3 μg/ml). These results support the notion that TXA2 is an important mediator in the present model of arterial thrombogenesis.

【 授权许可】

Unknown